"The better the surgeon, the better the outcomes." We will once again discuss with @ToDoenst the newest and most relevant publications in the field of coronary surgery in the last 12 months. Now on every podcast platform: https://t.co/tGyaEozbEN https://t.co/CMQ5BKnrtE

I love this card by Dr. Sarah Chen. Very creative and joyful as expected. 🫶🏻🙏🏻 Happy Holidays!

Gaining more experience with IndoCyanine Green during #TECAB to assess the patency and quality of the grafts. Very useful tool to implement #TTFM

🚨⚡️🇧🇬 Bulgaria has just shown the world once again that when a nation is pushed down and exploited, its people can still rise together and bring down a corrupt and manipulative government. Well done! ✊️👏🇧🇬

With more than 570 attendees, @ISCAScoronary #ICC2025 define itself as the best coronary surgery meeting in the World. From a Live #TECAB to lively discussion on #Afib #TTfM and #HF CABG to the keynote speech of @DrOz, ICC has set a new standard in the CT surgical meetings.

🔑 Fascinating keynote talks today at @ISCAScoronary: From a deep dive into how CABG and PCI truly differ, physiologically, pathologically, and clinically from @ToDoenst to an eye-opening look at the controversy shaping modern coronary trials @FaisalBakaeen @GianTorre610

Had a lively session with Paulina and Micheal ⁦@EACTS⁩. We learned that there is a lot of science in the art of mitral repair, that for non P2 prolapse PTFE chords work, for central MR jets a ring annuloplasty may suffice and in arrythmogenic MR: don’t watch or wait! #EACTS

🚨 Simultaneous publication: EACTS + JAMA! CABG-AF Trial (by German Hearts): Among 198 CABG pts with monitors, 48% developed POAF within 1 year. 👉 Median AF burden was minimal despite high incidence. It challenges current anticoagulation guidelines. 📖 https://t.co/GCKBhqDAzq

Please join me this Saturday at 8 AM EDT Time for another @ISCAScoronary Morning Talk about #OffPump #CABG How to learn it. Togehter with collegues and friends we will discuss how to become proficient in Off Pump. Event supported by @Medtronic https://t.co/NXjFVENOo7

@drjohnm @HrisKirov @divaka_perera If we keep calling PCI and CABG revascularization, we will keep blurring our perception of outcomes, because we do not understand the underlying treatment mechanisms ( https://t.co/gM9qSccvnc).

Objective and scientific. That is why we need more of @VictorDayan1 on guidelines

Performing CABG in severe LV EF is challenging! Did you know… 👉Beating-heart CABG with microaxial pump support (MPCAB) had 0% vs. 33% mortality compared to CPB-CABG in EF ~27%, (Assmann et al. 2025). 👉 Want to know more? Join us at #ICC2025 NYC

🫀 Tricuspid Valve Infective Endocarditis: Repair or Replacement? Excited to share our newly published systematic review and meta-analysis at @IJC_Heart_Vasc, addressing this critical surgical question. 📊 Across 19 retrospective cohorts and 9,734 patients, we compared

No trial better explains the importance of evidence than REVIVED BCIS. It boggles my mind that it was negative @divaka_perera is correct, but try telling 99% of American cardiologists We still cath new LV dys pts TO FIND LESIONS TO REVASC despite negative trials #ESC2025

🔥Hot off the press in @JCVAonline🔥 #TAVR vs #SAVR in pts with EF<50% 205 #PSM pairs No difference in 30d☠️, stroke and reinterventions PVL and MG⬆️with TAVI TAVR with ⬆️ ☠️ in 6y follow-up @IbrahimSultanMD @DSGMD @UPMC_CTSurgery @HviUpmc https://t.co/aOy76jL5wH

🚀 All-arterial, off-pump, no-touch aorta CABG 👨‍⚕️ 51y obese pt, RCA CTO, 3 failed CTO-PCI, CCS III angina, wanted durable solution w/o sternotomy. ✅ Approach: • LIMA+RIMA (I composite graft)→ PDA • MICS access ✨ Results: • Uneventful course • Home on POD 4

At @mainlinehealth our team has been advancing the practice of #RoboticCABG and #TECAB with two surgeons controlling three instruments during the anastomosis. This is possible thanks to an independent @Medtronic stabilizer. So much innovation still needed by the pathway is clear

🚑BREAKING NEWS. This is massive. 10 year PARTNER 2 data has been released by the company. No statistical analyses were performed. But I performed them and these is what happened at 10 years. @pomyers @rafasadaba @STS_CTsurgery @EACTS

From reconstructed KM curves, life tables + Parmar method, TAVR was associated with worse survival at 10 years. This is vital status sweep, so this is real. @drjohnm #cardiotweeter #TAVR #SAVR

15 surgeons. 5 countries. 1 mission: advancing minimally invasive cardiac surgery. A week of live cases, wetlabs & lectures at the Jena MICS Bootcamp = new skills, knowledge & network The winners? Our patients. Like 2x full-arterial, off-pump, no-touch-aorta MICS-CABG 🫀

What if the best vaccine against heart attacks… is surgery? 🫀 CABG cuts MI risk by 51% — on par with approved vaccines. It doesn’t just treat — it prevents. A collateral prevention system for the heart. 🧠💉 Read more: https://t.co/7taDzAbcCx